Aktis Oncology, Inc.
Income Statement
| Line Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Revenue | $27.4M | $27.1M | $15.4M | $6.6M | $1.8M | $1.3M |
| Fabrication Services Revenue | $11.2M | $9.0M | $1.9M | $2.8M | $991.0K | $1.1M |
| RF Filters Sales Revenue | $16.2M | $18.2M | $13.5M | $3.8M | $799.0K | $276.0K |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| Operating Expenses | ||||||
| Research & Development | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — |
| Operating Margin | — | — | — | — | — | — |
| Interest Expense | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| EPS (Basic) | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — |
| Shares Outstanding (Basic) | — | — | — | — | — | — |
| Shares Outstanding (Diluted) | — | — | — | — | — | — |
| Dividends Per Share | — | — | — | — | — | — |